Morning or bed-time insulin with or without glibenclamide in elderly Type 2 diabetic patients unresponsive to oral antidiabetic agents
- 31 December 1992
- journal article
- clinical trial
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 18 (3) , 185-190
- https://doi.org/10.1016/0168-8227(92)90144-g
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Insulin Therapy in Maturity-Onset DiabetesAnnals of Medicine, 1991
- Insulin Use in NIDDMDiabetes Care, 1990
- Combination Insulin-Sulfonylurea TherapyDiabetes Care, 1990
- Five-Year Follow-Up Study on Plasma Insulin Levels in Newly Diagnosed NIDDM Patients and Nondiabetic SubjectsDiabetes Care, 1990
- Effects of the combination of insulin and glibenclamide in Type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral hypoglycaemic agentsDiabetologia, 1988
- Selective unresponsiveness of pancreatic beta-cells to acute sulfonylurea stimulation during sulfonylurea therapy in NIDDMDiabetes, 1986
- Diabetes in the elderly: Diagnosis, pathogenesis, and therapyThe American Journal of Medicine, 1986
- NEW TACTICS FOR TYPE 2 DIABETES: REGIMENS BASED ON INTERMEDIATE-ACTING INSULIN TAKEN AT BEDTIMEThe Lancet, 1985
- Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatmentDiabetologia, 1980
- Clinical Pharmacology of Oral Antidiabetic AgentsNew England Journal of Medicine, 1977